BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ethosuximide readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Ethosuximide\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04217733-8982@assetmemo.bio
DTSTAMP:20261121T004035Z
DTSTART;VALUE=DATE:20301201
DTEND;VALUE=DATE:20301202
SUMMARY:Ethosuximide: Phase 3 readout est. (NCT04217733)
DESCRIPTION:Ethosuximide\, phase 3.\nStudy: Ethosuximide and Pentoxifylline
  in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome\nE
 stimated primary completion: 1 December 2030. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/ethosuximide#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT04217733
URL:https://assetmemo.bio/drug/ethosuximide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
